TRANCE is necessary and sufficient for osteoblast-mediated activation of bone resorption in osteoclasts

Journal of Experimental Medicine

Volumn 188, Issue 5, 1998, Pages 997-1001

  Fuller, Karen ^a   Wong, Brian ^c   Fox, Simon ^a   Choi, Yongwon ^b,c   Chambers, Tim J ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^c ROCKEFELLER UNIVERSITY   (United States)

Author keywords

Bone resorption; Osteoblast; Osteoclast; Parathyroid hormone; TRANCE

Indexed keywords

CYTOKINE; PARATHYROID HORMONE; TRANCE PROTEIN; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL INTERACTION; CELL SURVIVAL; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; MOUSE; NONHUMAN; OSTEOLYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ANIMALS; ANTIGENS, CD8; APOPTOSIS; BONE RESORPTION; CARRIER PROTEINS; CATTLE; CELL MOVEMENT; HUMANS; MEMBRANE GLYCOPROTEINS; MICE; OSTEOBLASTS; OSTEOCLASTS; PARATHYROID HORMONE; RANK LIGAND; RATS; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; RECOMBINANT FUSION PROTEINS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032494113     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.188.5.997     Document Type: Article

References (29)

1. Chambers, T.J. 1992. Regulation of osteoclast development and function. In Biology and Physiology of the Osteoclast. B.R. Rifkin and C.V. Gay, editors. CRC Press, Boca Raton, FL. 105-128.
2. Suda, T., N. Takahashi, and T.J. Martin. 1992. Modulation of osteoclast differentiation. Endocr. Rev. 13:66-79.
3. Wong, B.R., J. Rho, J. Arron, E. Robinson, J. Orlinick, M. Chao, S. Kalachikov, E. Cayani, F.S. Bartlett III, W.N. Frankel, et al. 1997. TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-jun N-terminal kinase in T cells. J. Biol. Chem. 272:25190-25194.
4. Wong, B.R., R. Josien, S.Y. Lee, B. Sauter, H.-L. Li, R.M. Steinman, and Y. Choi. 1997. TRANCE (tumor necrosis factor [TNF]-related activation-induced cytokine), a new TNF family member predominantly expressed in T cells, is a dendritic cell-specific survival factor. J. Exp. Med. 186:2075-2080.
5. Anderson, D.M., E. Maraskovsky, W.L. Billingsley, W.C. Dougall, M.E. Tometsko, E.R. Roux, M.C. Teepe, R.F. DuBose, D. Cosman, and L. Galibert. 1997. A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature. 390:175-179.
6. Yasuda, H., N. Shima, N. Nakagawa, K. Yamaguchi, M. Kinosaki, S.-I. Mochizuki, A. Tomoyasu, K. Yano, M. Goto, A. Murakami, et al. 1998. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and identical to TRANCE-RANKL. Proc. Natl. Acad. Sci. USA. 95:3597-3602.
7. Lacey, D.L., E. Timms, H.L. Tan, M.J. Kelley, C.R. Dunstan, T. Burgess, R. Elliott, A. Colombero, G. Elliott, S. Scully, et al. 1998. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell. 93: 165-176.
8. Chambers, T.J., P.M.J. McSheehy, B.M. Thomson, and K. Fuller. 1985. The effect of calcium-regulating hormones and prostaglandins on bone resorption by osteoclasts disaggregated from neonatal rabbit bones. Endocrinology. 116:234-239.
9. Fuller, K., J.M. Owens, C.J. Jagger, A. Wilson, R. Moss, and T.J. Chambers. 1993. Macrophage colony-stimulating factor stimulates survival and chemotactic behavior in isolated osteoclasts. J. Exp. Med. 178:1733-1744.
10. Burstone, M.S. 1958. Histochemical demonstration of acid phosphatases with naphthol AS-phosphate. J. Natl. Cancer Inst. 21:423-539.
11. Chambers, T.J., N.A. Athanasou, and K. Fuller. 1984. The effect of parathyroid hormone and calcitonin on the cytoplasmic spreading of isolated osteoclasts. J. Endocrinol. 102:281-286.
12. Kodama, H., A. Yamasaki, M. Abe, S. Niida, Y. Hakeda, and H. Kawashima. 1993. Transient recruitment of osteoclasts and expression of their function in osteopetrotic (op/op) mice by a single injection of macrophage colony-stimulating factor. J. Bone Miner. Res. 8:45-50.
13. McSheehy, P.M.J., and T.J. Chambers. 1986. Osteoblastic cells mediate osteoclastic responsiveness to parathyroid hormone. Endocrinology. 118:824-828.
14. Cayabyab, M., J.H. Phillips, and L.L. Lanier. 1994. CD40 preferentially co-stimulates activation of CD4+ T lymphocytes. J. Immunol. 152:1523-1531.
15. Bowman, M.R., M.A.V. Crimmins, J. Yetz-Aldape, R. Kriz, K. Kelleher, and S. Hermann. 1994. The cloning of CD70 and its identification as the ligand for CD27. J. Immunol. 152: 1756-1761.
16. Pollok, K.E., Y.J. Kim, J. Hurtado, Z. Zhou, K.K. Kim, and B.S. Kwon. 1994. 4-IBB T-cell antigen binds to mature B cells and macrophages, and costimulates anti-μ-primed splenic B cells. Eur. J. Immunol. 24:367-374.
17. Stüber, E., M. Neurath, D. Calderhead, H.P. Fell, and W. Strober. 1995. Cross-linking of OX40 ligand, a member of the TNF/NGF cytokine family induces proliferation and differentiation in murine splenic B cells. Immunity. 2:507-521.
18. Simonet, W.S., D.L. Lacey, C.R. Dunstan, M. Kelley, M.-S. Chang, R. Lüthy, H.Q. Nguyen, S. Wooden, L. Bennett, T. Boone, et al. 1997. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell. 89:309-319.
19. McSheehy, P.M.J., and T.J. Chambers. 1986. Osteoblast-like cells in the presence of parathyroid hormone release soluble factor that stimulates osteoclastic bone resorption. Endocrinology. 119:1654-1659.
20. Nicholson, G.C., G.N. Kent, D.J. Rowe, B.J. Cronin, R.S. Evely, and J.M. Moseley. 1989. PTH acts indirectly on isolated rat osteoclasts to increase resorption pit number. J. Bone Miner. Res. 4(Suppl. 1):S210.
21. Perry, H.M., W. Skogen, J. Chappel, A.J. Kahn, G. Wilner, and S.L. Teitelbaum. 1989. Partial characterization of a parathyroid hormone-stimulated resorption factor(s) from osteoblast-like cells. Endocrinology. 125:2075-2082.
22. Morris, C.A., M.E. Mitnick, E.C. Weir, M. Horowitz, B.L. Kreider, and K.L. Insogna. 1990. The parathyroid hormone-related protein stimulates human osteoblast-like cells to secrete a 9,000 dalton bone-resorbing protein. Endocrinology. 126:1783-1785.
23. Sahni, M., H.L. Guenther, H. Fleisch, P. Collin, and T.J. Martin. 1993. Bisphosphonates act on rat bone resorption through the mediation of osteoblasts. J. Clin. Invest. 91:2004-2011.
24. Thomson, B.M., J. Saklatvala, and T.J. Chambers. 1986. Osteoblasts mediate interleukin 1 stimulation of bone resorption by rat osteoclasts. J. Exp. Med. 164:104-112.
25. Chambers, T.J. 1982. Osteoblasts release osteoclasts from calcitonin-induced quiescence. J. Cell. Sci. 57:247-260.
26. Fuller, K., A.C. Gallagher, and T.J. Chambers. 1991. Osteoclast resorption-stimulating activity is associated with the osteoblast cell surface and/or the extracellular matrix. Biochem. Biopliys. Res. Commun. 181:67-73.
27. Cosman, D. 1994. A family of ligands for the TNF receptor superfamily. Stem Cells (Basel). 12:440-455.
28. Gruss, H.-J. 1996. Molecular, structural, and biological characteristics of the tumor necrosis factor ligand superfamily. Int. J. Clin. Lab. Res. 26:143-159.
29. Yao, G.Q., B.-h. Sun, E.E. Hammond, E.N. Spencer, M.C. Horowitz, K.L. Insogna, and E.C. Weir. 1998. The cell-surface form of colony-stimulating factor-1 is regulated by osteotropic agents and supports formation of multinucleated osteoclast-like cells. J. Biol. Chem. 273:4119-4128.